The effect of intravenous magnesium hypophosphite in calcium borogluconate solution on the serum concentration of inorganic phosphorus in healthy cows.
The goal of this study was to determine the effect of intravenous (IV) administration of phosphite on the serum concentration of inorganic phosphorus in cows. Twelve clinically healthy cows were divided into four groups of three. All cows received 600 mL of a 40% calcium borogluconate solution; three cows each received this as a rapid (20 min) IV infusion with and without 6% magnesium hypophosphite, and three other cows each received this as a slow IV infusion (8 h) with and without 6% magnesium hypophosphite. Samples of blood were collected for the determination of serum concentrations of calcium, inorganic phosphorus and magnesium before and 10, 20, 40, 60 and 90 min and 2, 3, 4, 5, 6, 7, 8, 24, 48 and 72 h after the start of treatment. The concentration of calcium increased after treatment in all cows but the increase was most rapid in cows that received the rapid infusion. In cows that received the rapid IV infusion containing magnesium hypophosphite, the mean concentration of inorganic phosphorus decreased significantly 3-4 h after treatment compared with initial serum levels. The serum concentration of inorganic phosphorus did not change significantly in cows that received the rapid IV solution without magnesium hypophosphite or the slow IV infusion with or without magnesium hypophosphite. The serum concentration of magnesium increased after treatment in all cows receiving magnesium hypophosphite but remained unchanged in the others. The rapid infusion of calcium borogluconate without magnesium hypophosphite made all three cows anorexic and hypercalcaemic and the slow infusion made 1/3 anorexic. It is concluded that the IV administration of a calcium solution containing magnesium hypophosphite does not increase the serum concentration of inorganic phosphorus.
Braun
U
U
Department of Farm Animals, University of Zurich, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland. ubraun@vetclinics.unizh.ch
Jehle
W
W
D000818:Animals; D001066:Appetite / Q000187:drug effects; D001888:Boric Acids / Q000008:administration & dosage*; D002118:Calcium / Q000008:administration & dosage / Q000493:pharmacokinetics; D002417:Cattle / Q000097:blood*; D005260:Female; D007275:Injections, Intravenous; D008274:Magnesium / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology*; D010721:Phosphinic Acids / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology*; D010758:Phosphorus / Q000097:blood*
D001888:Boric Acids; D010721:Phosphinic Acids; D010758:Phosphorus; C034286:borogluconate; D008274:Magnesium; D002118:Calcium